TOWERVIEW LLC – Eiger BioPharmaceuticals, Inc. Transaction History
TOWERVIEW LLC portfolio value:
$0
portfolio value
TOWERVIEW LLC quarter portfolio value change:
+19.52%
quarter
Eiger BioPharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -100.00% | -25K shares | -158K | $7.53 | 0 |
Q2 2022 | share | Decrease | -50.00% | -25K shares | -257K | $6.3 | 25K |
Q1 2022 | share | Decrease | -62.96% | -85K shares | -286K | $8.3 | 50K |
Q4 2021 | share | 0.00% | 0 shares | -201K | $5.21 | 135K | |
Q3 2021 | share | 0.00% | 0 shares | -248K | $6.68 | 135K | |
Q2 2021 | share | Decrease | -3.57% | -5K shares | -89K | $8.52 | 135K |
Q1 2021 | share | Increase | +7.69% | 10K shares | -359K | $8.85 | 140K |
Q4 2020 | share | Increase | +8.33% | 10K shares | 621K | $12.29 | 130K |
Q3 2020 | share | Increase | +54.84% | 42.5K shares | 233K | $8.14 | 120K |
Q2 2020 | share | Increase | 0.00% | 77.5K shares | 744K | $9.6 | 77.5K |